Anticipatory regulation for pandemic responses: are we there yet?

Trends Biotechnol. 2024 Mar 27:S0167-7799(24)00064-7. doi: 10.1016/j.tibtech.2024.02.016. Online ahead of print.ABSTRACTCan drug and vaccine regulatory agencies leverage their experience during the coronavirus disease 2019 (COVID-19) pandemic to advance from reactive regulation to adaptive regulation and beyond to anticipatory regulation to prevent or curb future pandemics?PMID:38538499 | DOI:10.1016/j.tibtech.2024.02.016

Source: Trends in Biotechnology - March 27, 2024 Category: Biotechnology Authors: Maria Giuliana Oyola-Lozada Lisette Pregelj Anna Jenkins Evan Siegel Trent Munro Damian Hine Source Type: research